Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors-Reference-Cited by-同舟云学术

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors

Published:2007 Issue:7 Volume:110 Page:1542-1550
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Nicholson H. Stacy,Kretschmar Cynthia S.,Krailo Mark,Bernstein Mark,Kadota Richard,Fort Daniel,Friedman Henry,Harris Michael B.,Tedeschi-Blok Nicole,Mazewski Claire,Sato Judith,Reaman Gregory H.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference47 articles.

1. , , et al. National Cancer Institute. SEER Cancer Statistics Review, 1973–1991. NIH Publication No. 94–2789. Bethesda, MD: National Institutes of Health; 1994.

2. Brain Tumors in Children

3. Treatment of Children With Medulloblastomas With Reduced-Dose Craniospinal Radiation Therapy and Adjuvant Chemotherapy: A Children's Cancer Group Study

4. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

5. Sensitivity of short-term cultures derived from human malignant glioma to the anti-cancer drug temozolomide

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy in pediatric low-grade gliomas (PLGG);Child's Nervous System;2024-05-31

2. Updates on management of gliomas in the molecular age;World Journal of Clinical Oncology;2024-02-24

3. Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review;Journal of Modern Oncology;2024-02-21

4. Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma;Clinical and Translational Medicine;2024-02

5. A phase 1 study of mebendazole with bevacizumab and irinotecan in high‐grade gliomas;Pediatric Blood & Cancer;2024-01-17